User:Ann Taylor/GLP-1 agonists
GLP-1 agonistsGLP-1 agonists
(GLP) are used to treat type 2 diabetes and obesity [1]. They GLP-1 agonists bind to the GLP receptor. The GLP receptor is a G-protein coupled receptor. Its secondary structure is highlighted in . The hydrophobic residues are shown in grey and the polar residues are shown in magenta in .
|
| ||||||||||
ReferencesReferences
- ↑ Drake T, Landsteiner A, Langsetmo L, MacDonald R, Anthony M, Kalinowski C, Ullman K, Billington CJ, Kaka A, Sultan S, Wilt TJ. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2024 Apr 19. PMID:38639549 doi:10.7326/M23-1490